<DOC>
	<DOCNO>NCT00972062</DOCNO>
	<brief_summary>The purpose study determine herbal over-the-counter cream decrease skin site reaction multiple sclerosis patient currently take either Betaseron , Copaxone Rebif subcutaneous medication manage multiple sclerosis . Injection site reaction indicate one major reason discontinue treatment subcutaneous medication ( Betaseron , Copaxone , Rebif ) multiple sclerosis .</brief_summary>
	<brief_title>Herbal Therapy Subcutaneous Injection Site Reactions Multiple Sclerosis</brief_title>
	<detailed_description>Skin site reaction account one likely reason discontinuation subcutaneous injection MS medication . It imperative additional method determine decrease reaction and/or treat reaction occur . Individuals continue use counter preparation ( e.g . Benadryl steroid cream ) treatment recently describe ( warm compress ) improve tolerance subcutaneous injection reaction . Both short ( 3 6 month ) long term skin reaction report patient . They complain office visit call nurse clinic teach injection technique . Recently , investigator nurse colleague find herbal cream ( Bach 's Rescue Remedy Cream ) reduce redness skin site reaction . A small investigator fund mini-pilot demonstrate decrease resolution size skin site reaction satisfaction herbal cream versus placebo cream . This propose research study build upon Moore 's previous success document significant decrease injection site reaction add air bubble injection injection , describe injection instruction Copaxone , Rebif , Axonex . The specific hypothesis study end point include : 1 . The herbal cream significantly decrease time redness base daily measure skin site reaction compare placebo cream . 2 . The herbal cream decrease discomfort skin site reaction measure visual analogue scale compare placebo cream . 3 . Participants indicate herbal cream make difference quality life base qualitative description effect skin site reaction herbal cream follow use herbal cream</detailed_description>
	<mesh_term>Sclerosis</mesh_term>
	<mesh_term>Multiple Sclerosis</mesh_term>
	<criteria>Participants must demonstrate redness skin site reaction Must demonstrate accurate injection technique prior initiate study Can read flexible measure record result . Are diagnosed secondary progressive , primary progressive Devic 's MS. Are take one three subcutaneous injection ( Betaseron® , Copaxone® Rebif® ) . Are pregnant . Are young 18 year age . Are use combination therapy ( e.g. , 2 immunomodulators , chemotherapy ) Have allergy topical cream use skin .</criteria>
	<gender>All</gender>
	<minimum_age>18 Years</minimum_age>
	<maximum_age>N/A</maximum_age>
	<verification_date>March 2012</verification_date>
	<keyword>Subcutaneous injection</keyword>
	<keyword>Skin abnormality</keyword>
</DOC>